Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Lymphoma

Free Subscription 02.03.2026 2 Blood 1 BMC Cancer 4 Br J Haematol 1 Clin Med Insights Oncol 4 Haematologica 1 Leuk Lymphoma 1 Mod Pathol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Blood

1. LI X, Liu M, Shi Q, Du ZS, et al
   CSNK1E Sustains Stem-like Drug Persistence in Diffuse Large B-cell Lymphoma.
   Blood. 2026 Feb 27:blood.2025031156. doi: 10.1182/blood.2025031156.
   PubMed         Abstract available
   
   
2. MARCOUX P, Gava F, Tosolini M, Gravelle P, et al
   Patient-Derived Lymphoma Spheroids Reveal Predictive Markers of Glofitamab Resistance in Relapsed/Refractory B-NHL.
   Blood. 2026 Feb 26:blood.2025031309. doi: 10.1182/blood.2025031309.
   PubMed         Abstract available
   
   

   
   BMC Cancer

3. HU S, Shen Z, Yang T, Xie Y, et al
   The prognostic value of metabolic heterogeneity parameter coefficient of variation (COV) of baseline (18)F-FDG PET/CT in newly diagnosed diffuse large B-cell lymphoma.
   BMC Cancer. 2026 Feb 23. doi: 10.1186/s12885-026-15760.
   PubMed         Abstract available
   
   

   
   Br J Haematol

4. LIU Y, Zhang J, Wang L, Liang Z, et al
   Association between body mass index and outcomes in lymphoma-associated haemophagocytic lymphohistiocytosis: A retrospective multicentre cohort study of Jiangsu Cooperative Lymphoma Group (JCLG).
   Br J Haematol. 2026 Feb 27. doi: 10.1111/bjh.70406.
   PubMed        
   
   
5. ARGNANI L, Stefoni V, Casadei B, Pelusi C, et al
   Immune-related adverse events in the treatment of Hodgkin lymphoma with immune checkpoint inhibitors.
   Br J Haematol. 2026 Feb 26. doi: 10.1111/bjh.70402.
   PubMed         Abstract available
   
   
6. MILES B, Mao D, Vardhanabhuti S, Bedognetti D, et al
   Predictive value of MRD monitoring by BCR clonality in the ZUMA-7 randomized clinical trial for CAR T therapy in r/r lymphoma.
   Br J Haematol. 2026 Feb 24. doi: 10.1111/bjh.70375.
   PubMed        
   
   
7. LIGIA S, Assanto GM, Soriano T, Cappelli LV, et al
   Prognostic impact of treatment-related and geriatric factors in older patients with classic Hodgkin lymphoma: A real-life cohort study.
   Br J Haematol. 2026 Feb 20. doi: 10.1111/bjh.70390.
   PubMed         Abstract available
   
   

   
   Clin Med Insights Oncol

8. CHEN LY, Tsai CA, Liao PW, Teng LC, et al
   Risk Factors for Febrile Neutropenia in Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma Undergoing Initial R-CHOP Treatment.
   Clin Med Insights Oncol. 2026;20:11795549261423995.
   PubMed         Abstract available
   
   

   
   Haematologica

9. KOCA O, Kucukyurt S, Eskazan AE
   Frontline therapy in primary mediastinal B-cell lymphoma: when salvage outcomes redefine the meaning of intensity. Comment on: Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma after frontline DA-EPOCH-R.
   Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2026.000004.
   PubMed         Abstract available
   
   
10. KUCHNIO A, Yang D, Vloemans N, Cornelissen I, et al
    Characterization of JNJ-80948543 a novel CD79bxCD20xCD3 trispecific antibody for B-cell non-Hodgkin lymphoma.
    Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2025.288473.
    PubMed         Abstract available
    
    
11. THARMASEELAN H, Sgonina LM, Buhnen I, Schnetzke U, et al
    Anti-programmed cell death protein 1-based salvage therapy for relapsed/refractory Hodgkin lymphoma: a multicenter real-world analysis.
    Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2025.288996.
    PubMed         Abstract available
    
    
12. DANN EJ
    Is it time to reduce the doxorubicin dosage in Hodgkin lymphoma therapy?
    Haematologica. 2026 Feb 26. doi: 10.3324/haematol.2025.289210.
    PubMed         Abstract available
    
    

    
    Leuk Lymphoma

13. BACHY E, Harnett J, Prochazka K, Townsend W, et al
    Comparative effectiveness of odronextamab monotherapy versus real-world systemic therapies in R/R follicular lymphoma.
    Leuk Lymphoma. 2026 Feb 24:1-12. doi: 10.1080/10428194.2026.2619500.
    PubMed         Abstract available
    
    

    
    Mod Pathol

14. MOMOSE S, Sawada K, Nedeva T, Yamamoto W, et al
    The Complexity and Challenges of Translating the Dark Zone Signature into Immunohistochemistry in Diffuse Large B-Cell Lymphoma.
    Mod Pathol. 2026 Feb 24:100979. doi: 10.1016/j.modpat.2026.100979.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Lymphoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum